Bosquetti Lucas Melo, Oliveira Cyntia Silva, Cerchiaro Giselle, Oliveira Junior Vani Xavier
Center of Human Sciences and Humanities, Federal University of ABC, Santo Andre, SP, Brazil.
São Paulo School of Medicine, Postgraduate Program in Molecular Biology, Federal University of São Paulo, Sao Paulo, SP, Brazil.
J Pept Sci. 2025 Feb;31(2):e3655. doi: 10.1002/psc.3655. Epub 2024 Oct 2.
Antimicrobial peptides (AMPs) are a promising source of new compounds against resistant bacteria. Temporins are a class of AMPs found on the amphibian Rana temporaria and show activity against Gram-positive and Gram-negative bacteria. There are few studies on how these antimicrobials have been used, but new Temporin-F derivatives were engineered with Lys-substitutions to assess the impact of the net charge on antimicrobial activity and toxicity. We demonstrated through some assays that it is possible to increase the antibacterial activity while maintaining a reduced peptide hemolytic activity with specific substitutions. Our lead synthetic peptide, G6K-Temporin F, has shown higher antimicrobial activity against Gram-negative and Gram-positive bacteria in vitro (MIC range 2 to 32 μmol L), with low hemolytic activity maintained, resulting in an increase in the therapeutic window (TW), of 12.5. Also, it showed more resistant to enzymatic degradation. On the other hand, more significant increases in net charges, such as in P3K-G11K-Temporin F, result in a severe increase in toxicity with lower gains in antimicrobial activity (TW of 0.65). In conclusion, we demonstrated that a moderate increase in net charge can lead to a more active analog and G6K-Temporin F is revealed to be promising as a candidate for new AMP therapeutics.
抗菌肽(AMPs)是对抗耐药菌的新化合物的一个有前景的来源。爪蟾素是在欧洲林蛙上发现的一类抗菌肽,对革兰氏阳性菌和革兰氏阴性菌均有活性。关于这些抗菌剂的使用方式的研究很少,但通过赖氨酸取代设计了新的爪蟾素-F衍生物,以评估净电荷对抗菌活性和毒性的影响。我们通过一些试验证明,通过特定取代可以在保持较低肽溶血活性的同时提高抗菌活性。我们的先导合成肽G6K-爪蟾素F在体外对革兰氏阴性菌和革兰氏阳性菌显示出更高的抗菌活性(MIC范围为2至32μmol/L),同时保持较低的溶血活性,导致治疗窗(TW)增加了12.5。此外,它对酶降解表现出更强的抗性。另一方面,净电荷的更显著增加,如在P3K-G11K-爪蟾素F中,会导致毒性严重增加,而抗菌活性的增加较少(TW为0.65)。总之,我们证明净电荷的适度增加可以导致更具活性的类似物,并且G6K-爪蟾素F被证明有望成为新型抗菌肽治疗剂的候选物。